AptarGroup, Inc. (ATR)

Market Cap	10.39B
Revenue (ttm)	3.57B
Net Income (ttm)	335.95M
Shares Out	66.54M
EPS (ttm)	4.98
PE Ratio	31.33
Forward PE	27.34
Dividend	$1.80 (1.15%)
Ex-Dividend Date	Oct 24, 2024

Volume	187,574
Open	156.97
Previous Close	156.41
Day's Range	155.68 - 157.95
52-Week Range	128.05 - 178.03
Beta	0.59
Analysts	Strong Buy
Price Target	195.00 (+24.93%)
Earnings Date	Feb 6, 2025

About ATR

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; an...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Apr 21, 1993
• Employees: 13,800
• Stock Exchange: NYSE
• Ticker Symbol: ATR
• Website: https://www.aptar.com

Financial Performance

In 2023, AptarGroup's revenue was $3.49 billion, an increase of 4.97% compared to the previous year's $3.32 billion. Earnings were $284.49 million, an increase of 18.89%.

Analyst Forecast

According to 5 analysts, the average rating for ATR stock is "Strong Buy." The 12-month stock price forecast is $195.0, which is an increase of 24.93% from the latest price.

Price Target

$195.0

(24.93% upside)

Analyst Consensus: Strong Buy